Clinical Research Directory

Inclusion Criteria: Diagnosed with type 2 diabetes mellitus for ≥6 months Fasting serum triglycerides between 200-399 mg/dL (based on the average of two measurements taken within a two-week period) Body mass index (BMI) between 25 and 35 kg/m² Age between 30 and 70 years If currently taking any medication for diabetes, dyslipidemia, or hypertension, the dose must have been stable for at least 8 weeks prior to enrollment, with confirmed adherence (having hypertension is not itself an inclusion requirement; only medication dose stability is required if such medication is being taken) Able to follow the prescribed diet Willing and able to provide informed consent Exclusion Criteria: Fasting triglycerides ≥400 mg/dL or \<200 mg/dL HbA1c \>10.5% eGFR \<30 mL/min/1.73m² Type 1 diabetes or rare/uncommon metabolic disorders Severe renal, cardiac, or hepatic disease, or active pancreatitis Established cardiovascular disease (myocardial infarction, stroke, coronary angioplasty or bypass surgery, or heart failure) - controlled hypertension alone does not exclude Pregnancy, breastfeeding, or planning pregnancy during the study Psychiatric disorder or social circumstances that would prevent adherence to the dietary protocol Change in dose or type of diabetes, lipid-lowering, or blood-pressure medication within the 8 weeks before enrollment or during the study Use of weight-loss medications, protein supplements, or probiotics Body weight change \>3% within the past 6 months (based on medical records or physician confirmation, not self-report alone) Withdrawal of consent to continue participation